USP1 inhibitors therapy(Satyarx Pharma)

N/A

Report date: 2023/11/21 16:22:27

Base Information

Drug NameUSP1 inhibitors therapy(Satyarx Pharma)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUbiquitin carboxyl-terminal hydrolase 1 inhibitors
TargetsUbiquitin carboxyl-terminal hydrolase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSatyarx Pharma Innovations Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSatyarx Pharma Innovations Pvt Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A